https://scholars.lib.ntu.edu.tw/handle/123456789/512471
標題: | Reply to S. Vale | 作者: | CHIA-CHI LIN JANN-YUAN WANG YEONG-SHIAU PU |
公開日期: | 2013 | 卷: | 31 | 期: | 20 | 起(迄)頁: | 2634-2635 | 來源出版物: | Journal of Clinical Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883892847&doi=10.1200%2fJCO.2013.49.6679&partnerID=40&md5=2d0a7540ba2f54367ea73b3110ac63d0 https://scholars.lib.ntu.edu.tw/handle/123456789/512471 |
ISSN: | 0732-183X | DOI: | 10.1200/JCO.2013.49.6679 | SDG/關鍵字: | bevacizumab; interleukin 10; temsirolimus; antineoplastic agent; comorbidity; disease predisposition; hematologic malignancy; human; kidney carcinoma; letter; lung lesion; Mycobacterium; patient monitoring; priority journal; protein blood level; tuberculosis; kidney carcinoma; kidney tumor; male; microbiology; note; tuberculosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Tuberculosis |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。